Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
MOA Magnifiers
Trabectedin: a DNA-Binding Agent That Covalently Interacts with the Minor Groove of the DNA Double Helix
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Necitumumab: an Epidermal Growth Factor Receptor Antibody
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Bavituximab: a Novel, Investigational Immunotherapy Agent Targeting Phosphatidylserine in the Vasculature of the Tumor Microenvironment
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Alectinib: an Anaplastic Lymphoma Kinase (ALK) Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Lenvatinib: a Receptor Tyrosine Kinase Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Abemaciclib (LY2835219): a Dual Inhibitor of CDK4 and CDK6
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Venetoclax (ABT-199): a Selective Inhibitor of B-Cell Lymphoma-2
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Ruxolitinib: a Kinase Inhibitor That Inhibits Overactive JAK Pathway Signaling
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Panobinostat: a Histone Deacetylase Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Idelalisib: a Selective Inhibitor of the Delta Isoform of Phosphatidylinositol 3-Kinase
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Page 1 of 2
1
2
Top Trending Articles
1.
HOPA Highlights: What's New in 2025?
2.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma